KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Rad Laboratories (BIO) Equity Average (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Equity Average for 16 consecutive years, with $7.1 billion as the latest value for Q4 2025.

  • Quarterly Equity Average rose 0.95% to $7.1 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.1 billion through Dec 2025, up 0.95% year-over-year, with the annual reading at $7.0 billion for FY2025, 8.41% down from the prior year.
  • Equity Average for Q4 2025 was $7.1 billion at Bio-Rad Laboratories, up from $6.9 billion in the prior quarter.
  • The five-year high for Equity Average was $14.5 billion in Q4 2021, with the low at $6.6 billion in Q1 2025.
  • Average Equity Average over 5 years is $9.1 billion, with a median of $8.8 billion recorded in 2022.
  • The sharpest move saw Equity Average surged 70.12% in 2021, then tumbled 37.65% in 2022.
  • Over 5 years, Equity Average stood at $14.5 billion in 2021, then plummeted by 37.65% to $9.0 billion in 2022, then decreased by 5.17% to $8.6 billion in 2023, then fell by 18.07% to $7.0 billion in 2024, then grew by 0.95% to $7.1 billion in 2025.
  • According to Business Quant data, Equity Average over the past three periods came in at $7.1 billion, $6.9 billion, and $6.9 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.